Literature DB >> 34908885

The Detection of Thyroid Nodules in Prediabetes Population and Analysis of Related Factors.

Xingyu Chang1,2, Yaqi Wang1,2, Songbo Fu1,2, Xulei Tang1,2, Jingfang Liu1,2, Nan Zhao1,2, Gaojing Jing1,2, Qianglong Niu1,2, Lihua Ma1,2, Weiping Teng3, Zhongyan Shan3.   

Abstract

PURPOSE: To explore the detection of thyroid nodules (TN) and related influencing factors in the population of prediabetes (PreDM) in northwest China's Gansu Province.
MATERIALS AND METHODS: A multi-stage stratified cluster random sampling method was used to select adult Han residents in Gansu Province for investigation, and recorded the clinical data of the subjects. The χ2 test was used to analyze the difference in TN detection rate of the PreDM population. Logistic regression analyzed the risk factors of TN in the PreDM population.
RESULTS: This study included 2659 people with normal glucose tolerance (NGT) and PreDM, of which 440 people were detected with TN. Among the PreDM population, the TN detection rate was higher than in the NGT population (24.48% vs 15.00%; P<0.05). The detection rate of TN in the impaired fasting glucose (IFG), impaired glucose tolerance (IGT) and IFG+IGT group was also significantly higher than that in the NGT population (X2=4.117, X2=13.187, X2=13.016, all P<0.05), and of which, the IFG+IGT group was the highest (32.20%). The general trend of TN in the IFG, IGT and PreDM population all increased with age. General data showed that BMI, waist-to-height ratio, waist circumference, TG, TC, LDL-C, FPG, 2h PG, HbA1c and TSH indicators in the TN group were higher than those in the Non-TN group (P<0.05). The logistic regression suggested that the risk factors for TN in the PreDM population were female, age increase, high SP, high TSH, high FPG, high LDL-C, hypertension and family history of diabetes (all P<0.05).
CONCLUSION: The detection rate of TN in the PreDM population is high, especially in the IFG+IGT population. Middle-aged and elderly people with hypertension and abnormal glucose and lipid metabolism should be treated reasonably and regularly, and their TN should be screened and followed up.
© 2021 Chang et al.

Entities:  

Keywords:  prediabetes; risk factors; thyroid nodules

Year:  2021        PMID: 34908885      PMCID: PMC8665774          DOI: 10.2147/RMHP.S337526

Source DB:  PubMed          Journal:  Risk Manag Healthc Policy        ISSN: 1179-1594


Introduction

PreDM is the transition state between normal glucose tolerance and diabetes.1 In recent years, with the rapid development of the economy, changes in people’s lifestyle and dietary structure, the prevalence of PreDM in adults in China has shown a rapid growth trend in the past decade, from 15.5% to 35.2%, and its prevention and treatment need to be paid great attention to.2,3 TN is a sporadic disease caused by the abnormal proliferation of local thyroid cells. The detection rate of TN in adults in China is about 20.4%, and there is a large disease base.4,5 Epidemiological investigation shows that the detection rate of TN in people with abnormal glucose metabolism is significantly increased, suggesting that there may be a certain connection between the two diseases.6 At present, the study of TN is mostly concentrated in the diabetic population, while the study of the PreDM population is less. This study focuses on the analysis of TN detection and related influencing factors in the adult PreDM population in Gansu Province, and provides reference ideas for clinical prevention of TN in the PreDM population.

Materials and Methods

Research Object

Selection method: a multi-stage stratified cluster random sampling method was used in Gansu Province. From September 4, 2016 to February 1, 2017, adult Han residents living in Lanzhou, Longnan, Dingxi, Baiyin and Linxia Prefecture for more than five years were randomly selected. Age 18–87 years, average (41.52±14.34) years. Exclusion criteria: (1) previous history of thyroid diseases; (2) patients who had received iodine-containing contrast agent examination or taken amiodarone in the past three months; (3) history of exposure to radioactive substances; (4) patients with severe liver and renal insufficiency; (5) patients with severe heart–brain dysfunction; (6) patients with malignant tumors; (7) diabetic patients; (8) pregnant women or lactating women; and (9) have taken drugs that interfere with blood lipids, blood pressure and thyroid function in the past 3 months, such as glucocorticoids, metoclopramide, propranolol and so on. Informed consent was signed by all participants (Medical Ethics Research Committee of the First Affiliated Hospital of China Medical University, AF-SOP-07-1.0-01).

Method

Common Data

Gender, age, height, weight, body mass index (BMI), waist circumference, heart rate, systolic blood pressure (SP), diastolic blood pressure (DP), family history of diabetes and history of hypertension were recorded.

Biochemical Index

(1) Blood lipid-related indexes: total cholesterol (TC, mmol/L), triglyceride (TG, mmol/L), high density lipoprotein cholesterol (HDL-C, mmol/L), low density lipoprotein cholesterol (LDL-C, mmol/L); (2) blood glucose-related indicators: fasting plasma glucose (FPG, mmol/L), 2h blood glucose after OGTT load (2h PG, mmol/L), glycosylated hemoglobin (HbA1c, %); (3) thyroid function examination: thyroid-stimulating hormone (TSH, mIU/L), anti-thyroid peroxidase antibody (TPOAb, IU/mL), and anti-thyroid globulin antibody (TgAb, IU/mL); and (4) other tests: urinary iodine (UIC, ug/L).

Prediabetes Diagnostic Criteria and Grouping

According to Guidelines for the Prevention and Treatment of Type 2 Diabetes in China (WHO 1999),1 the diagnostic criteria are as follows: (1) normal glucose tolerance (NGT): FPG<6.1 mmol/L and 2h PG<7.8 mmol/L; (2) prediabetes (PreDM): (a) impaired fasting glucose (IFG): 6.1 mmol/L≤FPG<7.0 mmol/L and 2h PG<7.8 mmol/L, (b) impaired glucose tolerance (IGT): 7.8 mmol/L≤2 hPG<11.1 mmol/L and FPG<6.1 mmol/L, (c) impaired glucose tolerance combined with impaired fasting glucose (IFG+IGT): 6.1 mmol/L≤FPG<7.0 mmol/L and 7.8 mmol/L≤2hPG<11.1 mmol/L; and (3) diabetes: FPG≥7.0 mmol/L or 2h PG≥11.1 mmol/L.

Thyroid Nodule

(1) Thyroid ultrasound examination: the examiner was supine, so that the head was reared and the shoulder was as high as possible, resulting in complete exposure of the anterior cervical region. The unified purchased B-ultrasound machine was used, GE General Motors, model LOGIQα100 (probe resolution 7.5 Hz). Ultrasound diagnosis evaluation was performed by two senior doctors with rich clinical experience to observe the size and morphology of TN. (2) Diagnosis of thyroid nodules: the diagnosis of thyroid nodules was performed according to the Guidelines for diagnosis and treatment of adult thyroid nodules and differentiated thyroid carcinoma released by the American Thyroid Association in 2015.7 The subjects were divided into the thyroid nodule group (TN group) and the non-thyroid nodule group (Non-TN group) according to whether they had thyroid nodule or not.

Statistical Method

SPSS 25.0 software was used for analysis. Normal distribution measurement data were expressed as (x±s). Two independent sample t test was used for comparison between the two groups. Count data were described by frequency. The difference in prevalence between the two groups was compared by the χ2 test. Logistic regression analysis model was used to analyze the possible risk factors of PreDM and its different subtypes, and the test level α=0.05. Non-normal distribution data were expressed as median (Median, M), 25th, 75th percentile (P25, P75). Mann–Whitney U test was used between the two groups. All the comparison results were statistically significant (P<0.05).

Results

Baseline Data Distribution of Survey Population

Baseline data of 2659 subjects, including region, education level, occupation, annual family income, are shown in Table 1.
Table 1

Baseline Data Distribution of Survey Population

CharacteristicsNumber of CasesComposition Ratio
Area
 Urban122446.03
 Rural143553.97
Education
 Illiteracy35813.46
 Primary school2268.50
 Junior high school43316.82
 Senior high school/technical secondary school42015.79
 Undergraduate/junior college114643.09
 Postgraduate762.96
Profession
 Worker67425.35
 Farmer102138.40
 Staff62823.62
 Housework572.14
 Student843.15
 Other1957.33
Family income (thousand yuan)
 ≤5782.93
 5~101676.28
 10~3058421.96
 30~5051819.48
 50~10083131.25
 >10048118.09
Baseline Data Distribution of Survey Population

Comparison of TN Detection Rate Between PreDM and Its Subtypes

In this study, a total of 2659 subjects were selected from NGT (2226 cases) and PreDM (433 cases), among which 440 patients with TN were found (187 males and 253 females). The results showed that the detection rate of TN in the PreDM population was 24. 48% (106/433). The detection rate of TN in male, female and total in the PreDM population were all significantly higher than that in the NGT population (X2=12. 87, X2=11. 81, X2=23. 57, all P<0. 001). Among all subtypes of PreDM, the detection rate of TN in the IFG+IGT population was the highest (32.20%), followed by IGT (23.34%) and IFG (22.99%) as shown in Table 2.
Table 2

Comparison of TN Detection Among Preiabetes and Its Subtypes Population

MaleFemaleP*χ2Total
nTN, n (%)nTN, n (%)nTN, n (%)
PreDM22949 (21.40)20457 (27.94)0.1142.50433106 (24.48)
 IFG4411 (25.00)439 (20.93)0.6520.208720 (22.99)
 IGT15028 (18.67)13739 (28.47)0.0503.8428767 (23.34)
 IFG+IGT3510 (28.57)249 (37.50)0.4710.525919 (32.20)
NGT1114138 (12.39)1112196 (17.63)0.00111.972226334 (15.00)
P#<0.001<0.001<0.001
 X212.8711.8123.57
 Total1343187 (13.92)1316253 (19.37)<0.00113.532659440

Notes: n: male or female; TN, n (%): patients with thyroid nodules, respective prevalence; P*: comparison of TN between male and female patients; P#: comparison of TN between PreDM and NGT population.

Comparison of TN Detection Among Preiabetes and Its Subtypes Population Notes: n: male or female; TN, n (%): patients with thyroid nodules, respective prevalence; P*: comparison of TN between male and female patients; P#: comparison of TN between PreDM and NGT population.

Distribution of TN Detection Rate in Different Age Groups Under Different Glucose Metabolism

The detection rates of TN in different subtypes of PreDM (IFG, IGT, IFG+IGT) were significantly higher than those in NGT (X2=4.117, X2=13.187, X2=13.016, all P<0.05). There was a statistically significant difference in the detection rate of TN among different age groups (PreDM, IFG, IGT) of different glucose metabolism groups (P<0.001), and they all showed an overall upward trend with age, as shown in Table 3.
Table 3

Distribution of TN Detection Rate in Different Age Groups Under Different Glucose Metabolism

GroupNGTPreDMPrevalence of TN in Different Subtypes of PreDM
IFGIGTIFG+ IGT
Agenn-TN(n, %)nn-TN (n, %)nn-TN (n, Constituent Ratio, %)nn-TN (n, Constituent Ratio, %)nn-TN (n, Constituent Ratio, %)
18~3072747 (6.46)324 (12.50)92 (50.00)222 (50.00)10 (0.00)
31~4056368 (12.08)565 (8.93)101 (20.00)404 (80.00)60 (0.00)
41~5048464 (13.22)1099 (8.26)272 (22.22)726 (66.66)101 (11.11)
51~6025771 (27.63)12233 (27.05)246 (18.18)8321 (63.64)156 (18.18)
≥6119584 (43.08)11455 (48.25)179 (16.36)7034 (61.82)2712 (21.82)
x2199.15860.59113.32840.6167.854
P<0.001<0.0010.010<0.0010.097
Total2226334 (15.00)433106 (24.48)8720 (22.99#)28767 (23.34#)5919 (32.20#)

Notes: n: total number; n-TN: number of patients with thyroid nodules; %: prevalence rate; P: comparison of TN detection among different ages; #comparison of TN between IFG/IGT/IFG+IGT and NGT, P<0.05.

Distribution of TN Detection Rate in Different Age Groups Under Different Glucose Metabolism Notes: n: total number; n-TN: number of patients with thyroid nodules; %: prevalence rate; P: comparison of TN detection among different ages; #comparison of TN between IFG/IGT/IFG+IGT and NGT, P<0.05.

Comparison of General Data Between TN Group and Non-TN Group

The subjects were divided into TN and Non-TN. The results showed that the age, BMI, SP, DP, waist–height ratio, waist circumference, FPG, 2h PG, TG, TC, LDL-C, HbA1c, TSH, TPOAb, TgAb of TN group were higher than those of the Non-TN group (P<0.05), and the urinary iodine level of the TN group was lower than that of the Non-TN group (P<0.05), as shown in Table 4.
Table 4

Comparison of General Information Between TN Group and Non-TN Group

CharacteristicsMale (n=1343)Female (n=1063)Total (n=2659)P
Non-TN (n=1156)TN (n=187)Non-TN (n=810)TN (n=253)Non-TN (n=2219)TN (n=440)t/z
Age39.81±13.7550.13±15.51*39.29±12.8752.27±14.89*39.57±13.3451.36±15.1815.18<0.001
BMI (kg/m2)24.24±3.2724.37±3.1522.44±3.1724±3.16*23.38±3.3524.15±3.164.49<0.001
SP (mmHg)125.47±14.68129.7±16.38*121.03±17.8134.53±22.53*123.34±16.39132.48±20.278.89<0.001
DP (mmHg)79.14±10.6480.39±10.6274.34±10.8578.36±12.43*76.84±1179.22±11.734.10<0.001
Waist-to-height ratio0.51±0.050.52±0.06#0.49±0.060.52±0.06*0.5±0.050.52±0.066.43<0.001
Waistline (cm)86.9±8.7488.02±9.878.29±8.7882.25±9.25*82.77±9.7684.7±9.93.77<0.001
FPG (mmol/L)5.15±0.615.28±0.59*5.06±0.595.31±0.53*5.1±0.65.3±0.566.22<0.001
2h PG (mmol/L)5.99±1.566.46±1.73*6.03±1.436.56±1.43*6.01±1.56.52±1.576.45<0.001
TG (mmol/L)1.6±1.131.78±1.1#1.27±0.991.55±1.04*1.45±1.081.65±1.073.67<0.001
TC (mmol/L)4.35±0.94.5±1.03#4.31±0.944.63±1.03*4.33±0.924.58±1.034.67<0.001
LDL-C (mmol/L)2.61±0.72.75±0.8#2.43±0.752.76±0.76*2.52±0.732.76±0.786.05<0.001
HbA1c (%)5.41±0.485.48±0.545.25±0.425.37±0.49*5.33±0.465.41±0.513.130.001
TSH (mIU/L)3.09±2.843.98±4.24*3.84±5.604.31±6.803.45±4.404.17±5.852.450.003
TPOAb (IU/mL)8.29 (6.32~11.47)8.91 (6.54~12.69)9.58 (6.62~15.76)10.86 (7.16~15.44)8.81 (6.46~13.36)9.79 (7.05~14.80)−2.610.009
TgAb (IU/mL)10.00 (10.00~14.22)10.00 (10.00~15.35)11.67 (10.00~24.41)12.52 (10.00~22.10)10.23 (10.00~17.00)11.08 (10.00~18.69)−2.160.031
UIC (ug/L)225.60 (162.88~307.20)214.10 (146.70~305.60)234.50 (155.40~342.50)213.50# (134.20~302.05)228.90 (158.55~319.55)213.60 (140.43~303.03)−2.880.004

Notes: P: Comparison between TN group and Non-TN group; */#comparison between TN group and non-TN group in male or female P<0.01/P<0.05.

Comparison of General Information Between TN Group and Non-TN Group Notes: P: Comparison between TN group and Non-TN group; */#comparison between TN group and non-TN group in male or female P<0.01/P<0.05.

Logistic Regression Analysis of Risk Factors for TN in Prediabetes Population with Different Subtypes

In the population of PreDM and its different subtypes, with TN as the dependent variable, the independent variables were screened by single factor analysis, and the multivariate analysis was performed. Finally, gender, age, BMI, SP, DP, TSH, family history of diabetes, HbA1c, hypertension, LDL-C were independent variables. The multivariate logistic regression equation showed that the risk factors for TN in the PreDM population were gender, age, high SP, high TSH, high FPG, family history of diabetes, hypertension, and high LDL-C (all P<0.05). The risk factors for TN in the IFG population were gender, age, and high TSH (all P<0.05). The risk factors for TN in the IFG population were gender and age (all P<0.05). The risk factors for TN in the IFG+IGT population were age, high SP, high HbA1c, hypertension, and high LDL-C (all P<0.05), as shown in Table 5.
Table 5

Logistic Regression Analysis of Risk Factors for TN in Different Subtypes of Prediabetes Population

PreDMIFGIGTIFG+IGT
CharacteristicsOR95% ClOR95% ClOR95% ClOR95% Cl
Sex0.5580.34~0.93*0.4430.22~0.88*0.4700.25~0.87*0.6680.20~2.22
Age1.0681.04~1.09*1.0541.01~1.10*1.0991.06~1.14*1.0921.03~1.16*
SP (mmHg)1.0311.01~1.05*1.0331.01~1.07*1.0181.01~1.03*1.0261.01~1.04*
TSH (mIU/L)1.0291.01~1.12*1.3281.02~1.76*1.0190.936~1.110.8370.63~1.21
Family history (DM)1.8341.01~3.36*2.0272.03~0.511.2320.65~2.340.7410.18~3.04
HbA1c (%)1.2630.82~1.961.0820.37~3.121.1580.68~1.985.9821.15~31.17*
Hypertension1.8081.09~2.98*1.1640.28~4.861.4160.75~2.674.3621.26~15.138*
LDL-C (mmol/L)1.3781.02~1.88*1.6700.75~3.721.1070.74~1.652.9051.14~7.39*

Note: *P<0.05.

Logistic Regression Analysis of Risk Factors for TN in Different Subtypes of Prediabetes Population Note: *P<0.05.

Discussion

With the continuous development of the social economy and the improvement of people’s living standards, the prevalence of PreDM in Chinese residents has shown a rapid growth trend, and abnormal glucose metabolism has gradually become an important influencing factor for many diseases.2 At the same time, as one of the most common thyroid diseases, the harmfulness of TN has attracted the attention of the whole society, but the influence mechanism between glucose metabolism and TN is not clear, which needs further study.8 The results of this study showed that the detection rate of TN in the PreDM population was significantly higher than that of NGT (24.48% vs 15.00%). Further gender stratification analysis of the PreDM population showed that this conclusion was also applicable, which was consistent with the results of Guo et al9 suggesting that elevated blood glucose might promote the formation of TN, and the PreDM population should pay attention to the occurrence of TN. We found that women were the risk factors of TN in IGT, suggesting that women with IGT should pay more attention to the prevention of TN, which is consistent with Ding et al10 who found that the prevalence of TN in women with impaired glucose metabolism is higher, but not in men. It may be that testosterone helps to prevent the harmful effects of IGT on men. No matter what type of prediabetes subtypes, this study found that the detection rate of TN in PreDM group was significantly higher than that in NGT group, and the detection rate of TN in IFG+IGT group (32.20%) was the highest. At the same time, HbA1c is a risk factor for TN in the IFG+IGT population. Blanc et al11 also found similar conclusions. Patients with abnormal glucose metabolism with higher HbA1c levels are more likely to suffer from TN, suggesting that for the IFG+IGT population, prevention and treatment of TN should be paid more attention, and HbA1c level may be the key indicator. Further analysis showed that the detection rate of TN in IFG, IGT and PreDM populations increased with age, especially in people over 61 years old. Age was also a risk factor for TN in PreDM and different subtypes. In this study, LDL-C was found to be a risk factor for TN in the PreDM population. Further comparative analysis showed that BMI, waist–height ratio, waist circumference, TG, TC, LDL-C and blood glucose-related indexes (FPG, 2h PG, HbA1c) in the TN group were higher than those in the Non-TN group. Buscemi et al12 showed that obesity and diabetes can promote the occurrence of TN, and further confirmed our results, suggesting that glucose and lipid metabolism is closely related to TN, we should pay attention to the relationship between glucose and lipid metabolism and thyroid disease. Logistic regression analysis showed that the risk factors for TN in the PreDM population were hypertension, high SP and high TSH. Chen et al13 also showed that patients with hypertension were more susceptible to TN, which is consistent with our study. Anil et al6 also found that people with impaired glucose metabolism had higher TSH levels, thyroid volume and nodule prevalence. Therefore, we should pay attention to the blood pressure and thyroid function of the PreDM population to reduce the incidence of TN. PreDM may lead to a higher prevalence of TN: hypothalamus–pituitary–thyroid axis regulation disorder. The leptin level in the high blood glucose population increases. Leptin can increase TSH secretion by stimulating the hypothalamus–pituitary–thyroid axis.6,14 And also play a direct role by regulating the expression of TRH gene in the paraventricular nucleus, thereby affecting the growth and differentiation of thyroid cells, leading to the occurrence of TN.15 Insulin resistance (IR): PreDM is often accompanied by IR. IR is considered to be a key factor in the pathogenesis of impaired glucose metabolism, which is closely related to the increase of TN detection rate.16 Hyperinsulinemia: PreDM people have higher insulin levels under abnormal glucose metabolism. On the one hand, insulin promotes the increase of total leptin level, thereby increasing the TSH level, resulting in TN.17 On the other hand, TSH and insulin/insulin-like growth factor 1 (IGF-1) signaling pathway together accelerate cell cycle to make cell proliferation, regulate gene expression and cause TN.18

Conclusion

In summary, TN is high in PreDM adults in Gansu Province, and the control of related risk factors should be paid attention to. Comprehensive attention should be paid to the effect of glucose and lipid metabolism and blood pressure levels on the occurrence and development of TN, especially the early screening of TN for elderly women and the corresponding intervention measures.
  18 in total

1.  Association between worse metabolic control and increased thyroid volume and nodular disease in elderly adults with metabolic syndrome.

Authors:  Evelyn Blanc; Cecilia Ponce; Dafne Brodschi; Alejandra Nepote; Adriana Barreto; Marta Schnitman; Pia Fossati; Pablo Salgado; Claudia Cejas; Cristina Faingold; Carla Musso; Gabriela Brenta
Journal:  Metab Syndr Relat Disord       Date:  2015-03-19       Impact factor: 1.894

2.  Association of obesity and diabetes with thyroid nodules.

Authors:  Silvio Buscemi; Fatima Maria Massenti; Sonya Vasto; Fabio Galvano; Carola Buscemi; Davide Corleo; Anna Maria Barile; Giuseppe Rosafio; Nadia Rini; Carla Giordano
Journal:  Endocrine       Date:  2017-08-23       Impact factor: 3.633

Review 3.  Leptin: metabolic control and regulation.

Authors:  Darleen A Sandoval; Stephen N Davis
Journal:  J Diabetes Complications       Date:  2003 Mar-Apr       Impact factor: 2.852

4.  Impaired glucose metabolism is a risk factor for increased thyroid volume and nodule prevalence in a mild-to-moderate iodine deficient area.

Authors:  Cuneyd Anil; Aysen Akkurt; Semra Ayturk; Altug Kut; Alptekin Gursoy
Journal:  Metabolism       Date:  2013-02-05       Impact factor: 8.694

Review 5.  Thyroid hormone regulation of metabolism.

Authors:  Rashmi Mullur; Yan-Yun Liu; Gregory A Brent
Journal:  Physiol Rev       Date:  2014-04       Impact factor: 37.312

6.  Gender Disparity in the Relationship between Prevalence of Thyroid Nodules and Metabolic Syndrome Components: The SHDC-CDPC Community-Based Study.

Authors:  Xiaoying Ding; Ying Xu; Yufan Wang; Xiaohua Li; Chunhua Lu; Jing Su; Yuting Chen; Yuhang Ma; Yanhua Yin; Yong Wu; Yaqiong Jin; Lihua Yu; Junyi Jiang; Naisi Zhao; Qingwu Yan; Andrew S Greenberg; Haiyan Sun; Mingyu Gu; Li Zhao; Yunhong Huang; Yijie Wu; Chunxian Qian; Yongde Peng
Journal:  Mediators Inflamm       Date:  2017-05-21       Impact factor: 4.711

Review 7.  Contemporary Thyroid Nodule Evaluation and Management.

Authors:  Giorgio Grani; Marialuisa Sponziello; Valeria Pecce; Valeria Ramundo; Cosimo Durante
Journal:  J Clin Endocrinol Metab       Date:  2020-09-01       Impact factor: 5.958

8.  Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study.

Authors:  Yongze Li; Di Teng; Xiaoguang Shi; Guijun Qin; Yingfen Qin; Huibiao Quan; Bingyin Shi; Hui Sun; Jianming Ba; Bing Chen; Jianling Du; Lanjie He; Xiaoyang Lai; Yanbo Li; Haiyi Chi; Eryuan Liao; Chao Liu; Libin Liu; Xulei Tang; Nanwei Tong; Guixia Wang; Jin-An Zhang; Youmin Wang; Yuanming Xue; Li Yan; Jing Yang; Lihui Yang; Yongli Yao; Zhen Ye; Qiao Zhang; Lihui Zhang; Jun Zhu; Mei Zhu; Guang Ning; Yiming Mu; Jiajun Zhao; Weiping Teng; Zhongyan Shan
Journal:  BMJ       Date:  2020-04-28

9.  The Association of Thyroid Nodules with Metabolic Status: A Cross-Sectional SPECT-China Study.

Authors:  Yi Chen; Chunfang Zhu; Yingchao Chen; Ningjian Wang; Qin Li; Bing Han; Li Zhao; Chi Chen; Hualing Zhai; Yingli Lu
Journal:  Int J Endocrinol       Date:  2018-03-06       Impact factor: 3.257

Review 10.  Thyroid Dysfunction and Type 2 Diabetes Mellitus: Screening Strategies and Implications for Management.

Authors:  Sanjay Kalra; Sameer Aggarwal; Deepak Khandelwal
Journal:  Diabetes Ther       Date:  2019-10-03       Impact factor: 2.945

View more
  1 in total

1.  Glucose Metabolism Derangements and Thyroid Nodules: Does Sex Matter?

Authors:  Alberto Gobbo; Irene Gagliardi; Andrea Gobbo; Roberta Rossi; Paola Franceschetti; Sabrina Lupo; Martina Rossi; Marta Bondanelli; Maria Rosaria Ambrosio; Maria Chiara Zatelli
Journal:  J Pers Med       Date:  2022-05-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.